B M Kaess1,2, A Pedley1, J M Massaro3, J Murabito4, U Hoffmann5, C S Fox6,7. 1. National Heart, Lung and Blood Institute's Framingham Heart Study, 73 Mt Wayte Ave Suite no. 2, Framingham, MA, 01702, USA. 2. Klinik und Poliklinik für Innere Medizin II, University of Regensburg, Regensburg, Germany. 3. Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA. 4. Boston University School of Medicine, Boston, MA, USA. 5. Radiology Department, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 6. National Heart, Lung and Blood Institute's Framingham Heart Study, 73 Mt Wayte Ave Suite no. 2, Framingham, MA, 01702, USA. foxca@nhlbi.nih.gov. 7. Brigham and Women's Division of Endocrinology, Hypertension, and Metabolism and Harvard Medical School, Boston, MA, USA. foxca@nhlbi.nih.gov.
Abstract
AIMS/HYPOTHESIS: The anatomic location of excess body fat has an impact on associated cardiometabolic morbidity, and visceral adipose tissue (VAT) is more pathogenic than subcutaneous adipose tissue (SAT). However, VAT or SAT alone provides little information regarding the relative distribution of body fat. We hypothesised that the propensity to store energy in VAT relative to SAT depots may be a correlate of cardiometabolic risk, and tested this hypothesis using the VAT/SAT ratio as a metric of fat distribution. METHODS: We investigated associations of the VAT/SAT ratio with cardiometabolic traits in 3,223 participants (48% women) from the Framingham Heart Study. Fat depots were quantified by multidetector computed tomography (CT) scanning. RESULTS: In women and men, higher VAT/SAT ratio was associated (p < 0.05) with most assessed cardiovascular risk factors reflecting blood pressure, dyslipidaemia and insulin resistance. Additional adjustment for BMI did not materially change the findings in women, and generally strengthened associations in men. Further adjustment for VAT attenuated some associations in women, but those with lower HDL-cholesterol, higher triacylglycerol (both p < 0.0001) and higher prevalence of hypertension (p = 0.02), diabetes (p = 0.01) and the metabolic syndrome (p = 0.005) remained significant. Similarly, in men, associations with higher systolic (p = 0.006) and diastolic blood pressure (p = 0.03), higher fasting glucose (p = 0.0005), lower HDL-cholesterol and higher triacylglycerol (both p < 0.0001) and higher prevalence of diabetes (p = 0.006) remained significant. CONCLUSIONS/ INTERPRETATION: VAT/SAT ratio is a correlate of cardiometabolic risk, above and beyond BMI and VAT. The propensity to store fat viscerally versus subcutaneously may be a unique risk factor independent of absolute fat volumes.
AIMS/HYPOTHESIS: The anatomic location of excess body fat has an impact on associated cardiometabolic morbidity, and visceral adipose tissue (VAT) is more pathogenic than subcutaneous adipose tissue (SAT). However, VAT or SAT alone provides little information regarding the relative distribution of body fat. We hypothesised that the propensity to store energy in VAT relative to SAT depots may be a correlate of cardiometabolic risk, and tested this hypothesis using the VAT/SAT ratio as a metric of fat distribution. METHODS: We investigated associations of the VAT/SAT ratio with cardiometabolic traits in 3,223 participants (48% women) from the Framingham Heart Study. Fat depots were quantified by multidetector computed tomography (CT) scanning. RESULTS: In women and men, higher VAT/SAT ratio was associated (p < 0.05) with most assessed cardiovascular risk factors reflecting blood pressure, dyslipidaemia and insulin resistance. Additional adjustment for BMI did not materially change the findings in women, and generally strengthened associations in men. Further adjustment for VAT attenuated some associations in women, but those with lower HDL-cholesterol, higher triacylglycerol (both p < 0.0001) and higher prevalence of hypertension (p = 0.02), diabetes (p = 0.01) and the metabolic syndrome (p = 0.005) remained significant. Similarly, in men, associations with higher systolic (p = 0.006) and diastolic blood pressure (p = 0.03), higher fasting glucose (p = 0.0005), lower HDL-cholesterol and higher triacylglycerol (both p < 0.0001) and higher prevalence of diabetes (p = 0.006) remained significant. CONCLUSIONS/ INTERPRETATION: VAT/SAT ratio is a correlate of cardiometabolic risk, above and beyond BMI and VAT. The propensity to store fat viscerally versus subcutaneously may be a unique risk factor independent of absolute fat volumes.
Authors: Ali H Mokdad; Earl S Ford; Barbara A Bowman; William H Dietz; Frank Vinicor; Virginia S Bales; James S Marks Journal: JAMA Date: 2003-01-01 Impact factor: 56.272
Authors: N E M Jaspers; J A N Dorresteijn; Y van der Graaf; J Westerink; L J Kappelle; H M Nathoe; A Algra; F L J Visseren Journal: Int J Obes (Lond) Date: 2017-08-04 Impact factor: 5.095
Authors: Roger Bouillon; Daniel J Drucker; Ele Ferrannini; Steven Grinspoon; Clifford J Rosen; Paul Zimmet Journal: Nat Rev Endocrinol Date: 2015-09-01 Impact factor: 43.330
Authors: Chun Seng Lee; David J Murphy; Colm McMahon; Blathnaid Nolan; Garret Cullen; Hugh Mulcahy; Kieran Sheahan; Elizabeth Barnes; David Fennelly; Elizabeth J Ryan; Glen A Doherty Journal: J Gastrointest Cancer Date: 2015-09
Authors: Jean Shin; Catriona Syme; Dominic Wang; Louis Richer; G Bruce Pike; Daniel Gaudet; Tomas Paus; Zdenka Pausova Journal: J Clin Endocrinol Metab Date: 2019-09-01 Impact factor: 5.958
Authors: Tom P Walsh; John B Arnold; Tiffany K Gill; Angela M Evans; Alison Yaxley; Catherine L Hill; E Michael Shanahan Journal: Rheumatol Int Date: 2017-05-17 Impact factor: 2.631